The European Association for the Study of the Liver (EASL) today publishes their revised Clinical Practice Guidelines (CPGs) on the management of hepatitis C virus infection (HCV) (1). The EASL guidelines, which supersede ...
Dec 9, 2013
0
0
The drug sofosbuvir has been available since January 2014 as a treatment for chronic hepatitis C infection. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the ...
May 2, 2014
0
0
An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection. However, large numbers of them are not even aware of their infection as they have not yet ...
Jul 26, 2017
0
0
While there are highly effective treatments for the hepatitis C virus (HCV), only one in five Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell ...
Aug 10, 2023
0
1
Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body's ability to keep the virus at bay, indicates a pilot study published online in the journal Gut.
Jul 17, 2012
0
0
A large-scale study evaluating the feasibility of decentralized care and the provision of free direct-acting antiviral agents (DAAs) has reported high rates of cure among a population of almost 20,000 individuals completing ...
Apr 12, 2018
0
2
An investigation published by The BMJ today reveals how the NHS is impeding access to high priced drugs for hepatitis C.
Jul 27, 2016
0
2
An innovative analysis combining geographic information systems (GIS), spatial epidemiology, and statistical modeling identified three hotspot clusters of hepatitis C infection rates in Massachusetts. The study, published ...
Apr 27, 2017
0
0
(HealthDay)—For HIV-infected women, anti-müllerian hormone is associated with age of menopause onset, according to a study published in the January issue of the American Journal of Obstetrics & Gynecology.
Jan 23, 2017
0
1
Researchers at the Sahlgrenska Academy, University of Gothenburg, have identified a gene, which explains why certain patients with chronic hepatitis C do not experience relapse after treatment. The discovery may contribute ...
Mar 13, 2014
0
0
